C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results
Author:
Affiliation:
1. Immunology Unit, Military University Hospital of Oran, HMRUO, Oran, Algeria
2. Scientific Council, Military University Hospital of Oran, HMRUO, Oran, Algeria
3. Unité Dialyse Enfant, Service de Réanimation Pédiatrique CHU, Oran, Algeria
Publisher
Informa UK Limited
Subject
Medical Laboratory Technology,Clinical Biochemistry,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/15321819.2016.1234485
Reference17 articles.
1. Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
2. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome
3. Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
4. Atypical Hemolytic Uremic Syndrome
5. Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Complement Inhibition for the Treatment of Myasthenia Gravis;ImmunoTargets and Therapy;2020-12
Complement Inhibition for the Treatment of Myasthenia Gravis
2. Semi-Solid Phase Assay for the Alternative Complement Pathway Activity Assessment (AP100);Biochemical Testing - Clinical Correlation and Diagnosis;2020-04-29
3. Semi-solid phase assay for the alternative complement pathway activity assessment (AP100);Journal of Immunoassay and Immunochemistry;2019-11-27
4. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report;American Journal of Case Reports;2019-10-04
5. Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation;Kidney Medicine;2019-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3